| Patent | Date |
|---|
Methods and antibody compositions for tumor treatment
Grant 11,434,300 - Smith , et al. September 6, 2 | 2022-09-06 |
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules That Bind PSMA and CD3, and Uses Thereof
App 20210403595 - Kirshner; Jessica R. ; et al. | 2021-12-30 |
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
Grant 11,155,633 - Kirshner , et al. October 26, 2 | 2021-10-26 |
Anti-egfrviii Antibodies And Uses Thereof
App 20210147557 - KIRSHNER; Jessica R. ; et al. | 2021-05-20 |
Anti-MUC16 antibodies
Grant 10,941,208 - Haber , et al. March 9, 2 | 2021-03-09 |
Use Of Bispecific Antigen-binding Molecules That Bind Muc16 And Cd3 In Combination With 4-1bb Co-stimulation
App 20200399371 - Kirshner; Jessica R. ; et al. | 2020-12-24 |
Use Of Bispecific Antigen-binding Molecules That Bind Psma And Cd3 In Combination With 4-1bb Co-stimulation
App 20200399372 - Kirshner; Jessica R. ; et al. | 2020-12-24 |
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind STEAP2 and CD3, and Uses Thereof
App 20200376136 - Rudge; John ; et al. | 2020-12-03 |
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereof
Grant 10,806,780 - Bray , et al. October 20, 2 | 2020-10-20 |
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof
App 20200317810 - Haber; Lauric ; et al. | 2020-10-08 |
Anti-STEAP2 antibody drug conjugates, and compositions and uses thereof
Grant 10,772,972 - Rudge , et al. September 15, 2 | 2020-09-15 |
Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
Grant 10,738,130 - Haber , et al. A | 2020-08-11 |
Anti-EGFRvIII antibodies and uses thereof
Grant 10,738,124 - Kirshner , et al. A | 2020-08-11 |
Antibody-drug conjugates comprising anti-prolactin receptor (PRLR) antibodies and methods of use thereof to kill PRLR-expressing cells
Grant 10,683,354 - Papadopoulos , et al. | 2020-06-16 |
Methods for tumor treatment using CD3XCD20 bispecific antibody
Grant 10,662,244 - Smith , et al. | 2020-05-26 |
Methods and Antibody Compositions for Tumor Treatment
App 20200115464 - Smith; Eric ; et al. | 2020-04-16 |
Methods and antibody compositions for tumor treatment
Grant 10,550,193 - Smith , et al. Fe | 2020-02-04 |
Anti-prlr Antibodies And Uses Thereof
App 20190241667 - Papadopoulos; Nicholas J. ; et al. | 2019-08-08 |
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bind PSMA and CD3, and Uses Thereof
App 20190127480 - Kirshner; Jessica R. ; et al. | 2019-05-02 |
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
Grant 10,179,819 - Kirshner , et al. Ja | 2019-01-15 |
Anti-human Papillomavirus (hpv) Antigen-binding Proteins And Methods Of Use Thereof
App 20190000956 - Bray; Kevin A. ; et al. | 2019-01-03 |
ANTI-EGFRvIII ANTIBODIES AND USES THEREOF
App 20180312594 - KIRSHNER; Jessica R. ; et al. | 2018-11-01 |
Antagonist antibodies to human prolactin receptor (PRLR)
Grant 10,106,616 - Papadopoulos , et al. October 23, 2 | 2018-10-23 |
Anti-EGFRvIII antibodies and uses thereof
Grant 10,047,160 - Kirshner , et al. August 14, 2 | 2018-08-14 |
Methods For Tumor Treatment Using Cd3xcd20 Bispecific Antibody
App 20180194841 - Smith; Eric ; et al. | 2018-07-12 |
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof
App 20180118848 - Haber; Lauric ; et al. | 2018-05-03 |
Anti-MUC16 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind MUC16 and CD3, and Uses Thereof
App 20180112001 - Haber; Lauric ; et al. | 2018-04-26 |
Anti-STEAP2 Antibodies, Antibody-Drug Conjugates, and Bispecific Antigen-Binding Molecules that Bind STEAP2 and CD3, and Uses Thereof
App 20180104357 - Rudge; John ; et al. | 2018-04-19 |
Anti-prlr Antibodies And Uses Thereof
App 20180094066 - PAPADOPOULOS; Nicholas J. ; et al. | 2018-04-05 |
Methods of treating breast cancer by administering anti-human prolactin receptor (PRLR) antibodies
Grant 9,688,764 - Papadopoulos , et al. June 27, 2 | 2017-06-27 |
Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bind PSMA and CD3, and Uses Thereof
App 20170051074 - Kirshner; Jessica R. ; et al. | 2017-02-23 |
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
Grant 9,545,451 - Papadopoulos , et al. January 17, 2 | 2017-01-17 |
Anti-EGFRvIII antibodies and uses thereof
Grant 9,475,875 - Kirshner , et al. October 25, 2 | 2016-10-25 |
ANTI-EGFRvIII ANTIBODIES AND USES THEREOF
App 20160304615 - KIRSHNER; Jessica R. ; et al. | 2016-10-20 |
Anti-prlr Antibodies And Uses Thereof
App 20160251442 - PAPADOPOULOS; Nicholas J. ; et al. | 2016-09-01 |
Anti-PRLR antibodies and methods for killing PRLR-expressing cells
Grant 9,302,015 - Papadopoulos , et al. April 5, 2 | 2016-04-05 |
Methods and Antibody Compositions for Tumor Treatment
App 20150266966 - Smith; Eric ; et al. | 2015-09-24 |
ANTI-EGFRvIII ANTIBODIES AND USES THEREOF
App 20150259423 - KIRSHNER; Jessica R. ; et al. | 2015-09-17 |
Anti-prlr Antibodies And Uses Thereof
App 20150056221 - PAPADOPOULOS; Nicholas J. ; et al. | 2015-02-26 |
Anti-prlr Antibodies And Uses Thereof
App 20150056222 - PAPADOPOULOS; Nicholas J. ; et al. | 2015-02-26 |
Method for treating cancer
App 20090093538 - Bertin; John ; et al. | 2009-04-09 |
| 